constructed a nanozyme (Pt@PCN222-Mn) with two catalytically active centres to target ROS overexpressed in the inflammatory milieu of IBD [96]
Advances in genetic research have identified mutations in genes involved in homocysteine metabolism (such as MTHFR) that can affect homocysteine levels and influence disease risk [8]
10.1007/s10545-011-9418-1 9
In preclinical research, 5-Amino-1MQ is primarily investigated for its ability to inhibit NNMT activity, which may influence multiple interconnected metabolic pathways
1 Introduction Cancer persists as the second leading cause of global mortality, with epidemiological projections estimating 19.97 million new cases and 9.74 million deaths in 2024 ( Nutraceuticals have emerged as compelling candidates in translational oncology, leveraging their dual capacity to potentiate anticancer effects while mitigating treatment-related toxicity ( 2 O 2 )-mediated responses, including adenosine triphosphate (ATP) depletion, iron-regulated epigenetic reprogramming, anti-apoptotic protein B cell lymphoma 2 (Bcl-2) inhibition, Bax (Bcl-2 associated X protein, a well-known pro-apoptotic mediator) activation, mitochondrial hyperpolarization induction, the cleavage of poly (ADP-ribose) polymerase (PARP, a known apoptotic indicator) and caspases, mainly caspases 3 and 7 as well as targeting hypoxia-inducible factor-1 ( HIF- ) ( The therapeutic application of VC in oncology has been plagued by persistent controversies, particularly regarding dose-response relationships and administration route efficacy
Ren X, Linehan MM, Iwasaki A, Pyle AM
